Sagility Limited (NSE:SAGILITY) has filed the transcript of its Q1 FY27 earnings conference call held on July 21, 2026, with the National Stock Exchange and BSE on July 28, 2026. The webinar, hosted by moderator Siddharth Rangnekar of CDR India, featured presentations and discussions led by Managing Director and Group CEO Ramesh Gopalan and Executive Vice President and Group Chief Financial Officer Srinivas Rathnam Mattapalli. The call covered the company's unaudited financial results for the quarter ended June 30, 2026, including commentary on operational performance, the recently closed CareSeed acquisition, and strategic market positioning in healthcare business process services.
Key Highlights
- Q1 FY27 revenue reached INR 19,635 million or $207.8 million, representing 27.6% year-on-year growth and 15.2% growth in constant currency terms.
- Adjusted EBITDA for Q1 FY27 was INR 4,716 million or $49.9 million, growing 27.9% year-on-year with a margin of 24%.
- Adjusted PAT increased to INR 2,697 million or $28.6 million, up 35.1% year-on-year, with a margin of 13.7%, despite absorbing annual salary increases and statutory minimum wage increases in Karnataka and Telangana.
- Organic revenue growth, excluding the CareSeed acquisition, was strong at 27.3% in INR terms and 14.9% in constant currency.
- The company signed $35.3 million of steady state Annual Contract Value across 18 existing clients and 1 new logo during Q1 FY27.
- Sagility closed the CareSeed acquisition in June 2026, adding 26 new clients in the mid- and small-market segments with HEDIS reporting and quality analytics capabilities.
- Employee strength reached 47,307 at the end of Q1, with quarterly voluntary attrition improving significantly to 28.6% from 38.1% in Q4 FY26.
About the Company
Sagility Limited (NSE:SAGILITY, BSE:544282), formerly known as Sagility India Limited, is a Bengaluru-headquartered healthcare business process services provider. The company operates across the healthcare value chain, serving payers and providers through claims processing, adjustments, revenue cycle management, quality analytics, clinical and care management, and population health solutions. Its client base includes major U.S. health plans and healthcare organizations. The company has established a global delivery footprint with operations in India and serves clients across Medicare Advantage, commercial, and Medicaid segments. Sagility's technology platforms include Sagility Synchrony, an AI-led orchestration platform for claims and adjustments workflows, and solutions for HEDIS reporting and quality analytics following the CareSeed acquisition completed in June 2026. The company is registered with Corporate Identification Number L72900KA2021PLC150054 and maintains its registered office in Bengaluru, Karnataka.
Announcement in Detail
Sagility Limited filed the complete transcript of its Q1 FY27 earnings conference call with both the National Stock Exchange of India Limited and BSE Limited on July 28, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The webinar, moderated by Siddharth Rangnekar from CDR India, was conducted on Tuesday, July 21, 2026 at 7:30 pm and included presentations from the company's senior management team and responses to questions from institutional investors and equity analysts including representatives from Jefferies, Unifi Capital, Axis Capital, Kotak Securities, IIFL Capital, ICICI Securities, Elara Capital, Demeter Advisors, and A Square Advisors.
During the call, Managing Director and Group CEO Ramesh Gopalan provided an overview of market conditions in U.S. healthcare, highlighting that leading payers continue to prioritize margin protection, cost discipline, and medical utilization management. The management noted that demand favors partners combining deep healthcare domain expertise with operational scale, technology capabilities, AI solutions, and demonstrated ability to deliver measurable outcomes. Gopalan highlighted the company's strategic direction toward integrated, outcome-driven operating frameworks and discussed the success of managed service deal constructs where Sagility takes operational ownership and accountability for delivering committed outcomes. He emphasized traction with Sagility Synchrony, the company's AI-led orchestration platform connecting fragmented workflows across claims and adjustments.
The filing disclosed that the company closed the CareSeed acquisition in June 2026. CareSeed, founded in 2012 and headquartered in Kansas City, generated CY 2025 revenue of $5.1 million with 95% recurring revenue and a 31.4% EBITDA margin. The acquisition brought 30 clients under CareSeed's platform, with 26 of these clients representing new relationships to Sagility and each generating less than $1 million in revenue. CareSeed operates two technology platforms: Forecast, providing HEDIS reporting and quality analytics, and Harvest, delivering cloud-based medical record review and chart abstraction services. The transaction strengthened Sagility's capabilities in quality operations for Medicare Advantage plans across HEDIS, CMS Stars, quality reporting, and care-gap orchestration, while adding a skilled 14-member team with expertise in quality, technology, and client management.
Impact on Investors
Investors will note that the disclosed Q1 FY27 financial performance demonstrates revenue growth across multiple dimensions. The 27.6% year-on-year growth in reported INR revenue and 15.2% growth in constant currency terms indicates the company is expanding its revenue base despite headwinds from rising operational costs, including statutory minimum wage increases in Karnataka and Telangana implemented during the quarter. The adjusted EBITDA margin of 24% and adjusted PAT margin of 13.7%, both expanding year-on-year despite the absorption of these cost pressures, signal operational efficiency gains. The filing shows payers contributed 89.6% of revenues while providers accounted for 10.4%, reflecting concentration in the payer segment. Organic growth of 27.3% in INR terms, excluding the CareSeed acquisition, demonstrates that performance is not solely attributable to inorganic expansion.
The CareSeed acquisition introduces new revenue streams and capability diversification into quality and HEDIS operations, a segment where Sagility previously had limited presence. The acquisition added 26 mid- and small-market segment clients, each currently generating less than $1 million in revenue, which represents a market expansion opportunity distinct from the company's existing large-payer focus. However, investors will observe that the disclosed integration creates a dependency on technology platform synergies between CareSeed's Forecast and Harvest platforms and Sagility's existing clinical and population health capabilities to realize stated value creation. The filing indicates voluntary attrition improved to 28.6% in Q1 FY27 from 38.1% in Q4 FY26, suggesting talent retention improvements, though the Q1 figure remained marginally higher than Q1 FY26 levels. The active client count increased to 109 client groups following CareSeed integration, expanding the diversification of the revenue base across healthcare payers.
Sector / Market Context
The U.S. healthcare sector context disclosed during the management commentary reflects ongoing structural pressures on health plan economics. According to the call transcript, U.S. healthcare organizations continue operating in an environment prioritizing margin protection, cost discipline, and medical utilization management. Select payers have reported improved or lower medical utilization trends; however, the broader market continues experiencing pressure from rising utilization rates, increasing medical costs, regulatory complexity, and membership volatility. This backdrop has created demand for outsourced healthcare business process services providers capable of delivering measurable operational and financial outcomes at reduced cost structures. Healthcare business process outsourcing has become increasingly critical as leading payers focus on clinical and care management effectiveness, Stars performance improvement, and administrative cost reduction initiatives.
The healthcare services segment in India has established itself as a significant delivery hub for global healthcare payers and providers seeking cost-effective operations combined with clinical expertise. The competitive positioning described in the earnings call references recognition from industry analysts including placement in Intelligent Operations PEAK Matrix assessments by analysts covering healthcare CXM and Revenue Cycle Management spaces. The company's human capital competitiveness is reflected in its first-time ranking as 11th amongst India's 100 best companies to work for in 2026 by Great Place to Work India, and recognition by ET Edge among best organizations for women. These external validations position healthcare service providers like Sagility within a broader narrative of India-based delivery centers differentiating through talent quality, technology infrastructure, and clinical capability depth rather than cost arbitrage alone.